Thermo Fisher Q1 revenue beats on Clario acquisition boost

Thermo Fisher Scientific

23/04/2026 11:09

Overview

Lab equipment and services provider's Q1 revenue grew 6%, beating analyst expectations

Adjusted EPS for Q1 rose 6%, beating analyst expectations

Company completed Clario acquisition and repurchased $3.0 bln of stock

Outlook

Company will provide updated 2026 financial guidance during its earnings conference call

Thermo Fisher says it is well positioned to deliver a strong year

Result Drivers

NEW PRODUCT LAUNCHES - Co said Q1 results were supported by launches of new instruments and systems, including Glacios 3 Cryo-TEM and TSQ Certis mass spectrometer

ACQUISITION IMPACT - Clario acquisition contributed to strengthening capabilities and revenue growth, per CEO Marc Casper

STRATEGIC COLLABORATIONS - Partnerships with NVIDIA and SHL Medical aimed to advance scientific instrumentation and manufacturing solutions

Company press release: ID:nBw9jY4rYa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$11.01 bln
$10.85 bln (18 Analysts)
Q1 Adjusted EPS
Beat
$5.44
$5.24 (20 Analysts)
Q1 EPS
$4.43
Q1 Adjusted Net Income
Beat
$2.03 bln
$1.96 bln (15 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 27 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Thermo Fisher Scientific Inc is $630.34, about 22.6% above its April 22 closing price of $513.98

The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 24 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)